Search
Back

Epirubicin HCl

CAS 56390-09-1
Epirubicin HCl

General Information

Epirubicin HCl belongs to a class of drugs termed anthracyclines and is primarily used for the treatment of breast cancers after surgical resection. Anthracyclines are a type of antibiotic isolated from the gram-positive bacteria Streptomyces.


About the API

Technology Synthetic
Therapeutic category Oncology
Systematic Name (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
Available formulations Injectables
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.